Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer
Clinical trial NCT02324335 · COMPLETED
Trial details
- NCT number
- NCT02324335
- Sponsor
- Innovation Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-14
- Primary completion
- 2017-10-25
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.